GINNA GONZALEZ: Open Payments
NPI 1811171531 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 12 payments from 7 companies in 2025. Trend: 2023 $7,719 · 2024 $300 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | 3 | $189 |
| Sarepta Therapeutics, Inc. | 1 | $83 |
| Tanabe Pharma America, Inc. | 3 | $70 |
| Genentech USA, Inc. | 2 | $60 |
| ITF Therapeutics LLC | 1 | $27 |
| Biogen, Inc. | 1 | $25 |
| Philips North America LLC | 1 | $15 |
Products named: AGAMREE, Radicava, Evrysdi, SPINRAZA, Vest Therapy Und.
Industry payments across FL — which companies pay providers there.
